Steris Healthcare Private Limited

IPRATROP LD is a premium respiratory formulation designed to effectively manage obstructive airway disorders. Each dose contains Levosalbutamol (0.63 mg) and Ipratropium Bromide (500 mcg), a powerful combination that delivers quick relief from bronchoconstriction and breathing difficulties. Levosalbutamol acts as a potent bronchodilator by relaxing airway muscles, while Ipratropium Bromide, an anticholinergic, reduces airway secretions and prevents bronchospasm. Together, they offer comprehensive symptom control for patients with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory ailments.

This formulation is appropriate for use in both adults and children under medical supervision, providing rapid and sustained relief from wheezing, shortness of breath, and chest tightness. Delivered via inhalation, the medicine targets the lungs directly, ensuring maximum effectiveness with minimal systemic side effects.

Uses

IPRATROP LD is commonly prescribed for:

• Managing asthma by alleviating acute attacks and maintaining open airways.

• Treating COPD symptoms such as wheezing, coughing, and breathlessness.

• Preventing bronchospasms triggered by allergens, pollutants, or exercise.

• Managing respiratory distress associated with acute or chronic bronchitis.

This combination therapy is preferred when a single bronchodilator does not adequately control symptoms, as it addresses both airway constriction and excessive mucus production.

Benefits

IPRATROP LD provides several advantages for patients with respiratory conditions:

• Rapid bronchodilation through Levosalbutamol’s relaxation of airway smooth muscles.

• Decreased mucus secretion thanks to Ipratropium Bromide’s anticholinergic effects.

• Dual-action mechanism offering thorough symptom relief.

• Fast onset of action, with relief beginning within minutes, suitable for emergency situations.

• Improved lung function during ongoing treatment.

• Targeted inhalation delivery maximizes lung effects while minimizing systemic absorption and side effects.

Dosage

Dosage should always follow medical advice. Typical recommendations include:

• Adults: 1–2 inhalations (0.63 mg Levosalbutamol + 500 mcg Ipratropium Bromide) 2–3 times daily.

• Children: Dosage varies by age and condition severity; consult a pediatrician.

Important: Shake well before use and follow device instructions carefully. Avoid exceeding prescribed doses to reduce the risk of side effects.

Side Effects

While generally safe, some users may experience mild side effects such as tremors, nervousness, headache, dizziness, dry mouth, or mild throat irritation. Rare side effects include rapid heartbeat or allergic reactions like rash or swelling. Seek immediate medical attention if severe reactions occur. Patients with heart conditions or hypertension should be monitored regularly.

Precautions and Warnings

Before using IPRATROP LD, inform your doctor if you have any history of heart disease, high blood pressure, glaucoma, or urinary retention. Use during pregnancy or breastfeeding only under a doctor’s supervision. Disclose all current medications, especially beta-blockers or other bronchodilators. Store the medication in a cool, dry place away from sunlight and out of reach of children. Do not share inhalers or nebulizers to avoid infection risks.

This medication relieves symptoms but does not cure the underlying disease. Regular medical follow-up is necessary for effective respiratory management.